ADCYAP1 and experimental autoimmune encephalomyelitis: Potent anti-inflammatory effects of exogenous PACAP have been proven in experimental autoimmune encephalomyelitis [7] and arthritis [8], for instance, whereas data regarding inflammation-dampening effects within the gastrointestinal tract are scarce.